Mr. Gregory Crawford reports

QUIPT HOME MEDICAL CORP. ANNOUNCES FILING OF PRELIMINARY BASE SHELF PROSPECTUS TO REPLACE RECENTLY EXPIRED BASE SHELF PROSPECTUS

Quipt Home Medical Corp. has filed a preliminary short-form base shelf prospectus with the securities commissions in each of the provinces and territories of Canada, and a corresponding registration statement on Form F-10 with the United States Securities and Exchange Commission under the U.S./Canada Multijurisdictional Disclosure System. The shelf prospectus and registration statement, when made final and effective, will enable the company to offer up to $300-million of common shares, preferred shares, debt securities, warrants to acquire any of the securities that are described in the shelf prospectus, subscription receipts, and units comprising any one or more of any of the other securities that are described in the shelf prospectus, or any combination thereof, at any time during the 25-month period that the shelf prospectus remains effective.

The shelf prospectus will enable the company to access new capital or issue securities in connection with strategic acquisitions if and when needed. The amount and timing of any future offerings or issuances will be based on the company's financial requirements and market conditions at that time.

The filing of the shelf prospectus replaces and is made for the purpose of restoring the original financing capacity of $200-million, which was available to the company under its previous short-form base shelf prospectus dated Nov. 11, 2021, that expired on Dec. 13, 2023, and the filing of the registration statement replaced the company's previous registration statement on Form F-10 that was declared effective on Nov. 15, 2021, plus an additional $100-million resulting in a total offering amount of up to $300-million.

The terms of future offerings or issuances under the shelf prospectus, the intended use of the net proceeds resulting from such offerings, and the terms of the securities to be offered, if any, will be established at the time of any such offering and will be described in a prospectus supplement filed with the applicable Canadian securities commissions at the time of such an offering.

A copy of the shelf prospectus is available on SEDAR+ and on EDGAR, or may be obtained by request from the secretary of the company at 1019 Town Dr. Wilder, Kentucky, United States, 41076, telephone: 859-878-2220.

About Quipt Home Medical Corp.

The company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States health care market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient.

We seek Safe Harbor.